trial · primary record
Elecoglipron
Type 2 Diabetes Mellitus
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 2000 |
| Primary completion | 2028-07-05 |
| Primary endpoint | Change from baseline in Hemoglobin A1c (HbA1c) |
| Registry ID | NCT07662109 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:06.162Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07662109
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.